Research
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study
-
* Corresponding author: Peter Lackner peter.lackner@i-med.ac.at
Malaria Journal 2009, 8:36 doi:10.1186/1475-2875-8-36
No comments have yet been made on this article.